Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The debt to assets ratio is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.00%
DEBT TO ASSETS RATIO AVG 3Y
0.00%
DEBT TO ASSETS RATIO AVG 5Y
0.00%
DEBT TO ASSETS RATIO AVG 10Y
0.53%
DEBT TO ASSETS RATIO AVG 15Y
0.27%
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
-100.00%
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Relmada Therapeutics, Inc.
Market Cap
$347.71M
Debt to Assets Ratio
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$349.71M
Debt to Assets Ratio
0.36%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$353.33M
Debt to Assets Ratio
0.61%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$357.08M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$357.08M
Debt to Assets Ratio
0.19%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$357.88M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$358.14M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Relmada Therapeutics, Inc. (RLMD) | $347.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| Turn Therapeutics Inc. (TTRX)vs › | $349.71M | 0.36% | N/A | N/A | N/A |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $353.33M | 0.61% | N/A | N/A | N/A |
| Viemed Healthcare, Inc. (VMD)vs › | $357.08M | 0.06% | N/A | N/A | N/A |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $357.08M | 0.19% | N/A | N/A | N/A |
| Embecta Corp. (EMBC)vs › | $357.32M | 1.19% | N/A | N/A | N/A |
| Ocugen, Inc. (OCGN)vs › | $357.76M | 0.71% | N/A | N/A | N/A |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $357.88M | 0.03% | N/A | N/A | N/A |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $358.14M | 0.00% | N/A | N/A | N/A |
| Opus Genetics, Inc. (IRD)vs › | $366.25M | 0.38% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
29.52
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.22% |
| 2019-12-31 | 0.09% |
| 2019-09-30 | 3.01% |
| 2019-06-30 | 3.56% |
| 2019-03-31 | 1.10% |
| 2018-12-31 | 3.48% |
| 2018-09-30 | 218.07% |
| 2018-06-30 | 96.51% |
| 2018-03-31 | 33.45% |
| 2017-12-31 | 21.13% |
| 2017-09-30 | 15.55% |
| 2017-06-30 | 9.75% |
| 2017-03-31 | 0.66% |
| 2016-12-31 | 1.77% |
| 2016-09-30 | 2.08% |
| 2016-06-30 | 2.67% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.53% |
| 2015-09-30 | 0.86% |
| 2015-06-30 | 1.08% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.12% |
| 2014-09-30 | 0.53% |
| 2014-06-30 | 0.23% |
| 2014-02-28 | 0.00% |
| 2013-11-30 | 0.00% |
| 2013-08-31 | 4219.56% |
| 2013-05-31 | 0.00% |
| 2013-02-28 | 0.00% |
| 2012-08-31 | 0.00% |
